![](http://apasl.info/app-def/S-102/apasl/wp-content/uploads/2017/08/APASL2017_tberg-192x114.jpg)
Finite Treatment with NUCs
URL | http://ic-hep.com/webcasts/apasl2017/tberg/ |
---|---|
Speaker | Thomas BERG, Leipzig |
![](http://apasl.info/app-def/S-102/apasl/wp-content/uploads/2017/08/APASL2017_sgee-192x114.jpg)
Clinical Decision Making of NUCs Therapy in HBV Patients in 2016/2017
URL | http://ic-hep.com/webcasts/apasl2017/sgee/ |
---|---|
Speaker | Seng-Gee LIM, Singapore |
![](http://apasl.info/app-def/S-102/apasl/wp-content/uploads/2017/08/apasl2017_jliang-192x114.jpg)
Hepatitis C: What Next after the Discovery of DAAs
URL | http://ic-hep.com/webcasts/apasl2017/jliang/ |
---|---|
Speaker | T. Jake LIANG, Bethesda |
![](http://apasl.info/app-def/S-102/apasl/wp-content/uploads/2017/08/APASL2017_myu-192x114.jpg)
Countries and Regions Waiting Approval for DAAs – What is the Best Management Strategies?
URL | http://ic-hep.com/webcasts/apasl2017/myu/ |
---|---|
Speaker | Ming-Lung YU, Kaohsiung |
![](http://apasl.info/app-def/S-102/apasl/wp-content/uploads/2017/08/APASL2017_srahman-192x114.jpg)
Developing Countries and Regions – What Is the Role of Generic Drugs
URL | http://ic-hep.com/webcasts/apasl2017/srahman/ |
---|---|
Speaker | Salimur RAHMAN, Dhaka |